West Pharmaceutical Services

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$748,800
$746,900
$702,000
$695,400
Gross Profit
273,600
264,700
231,300
230,200
EBITDA
204,800
205,400
168,400
161,200
EBIT
164,100
165,200
129,500
125,600
Net Income
130,100
136,000
111,300
115,300
Net Change In Cash
748,800
746,900
702,000
695,400
Free Cash Flow
85,200
98,800
64,800
27,600
Cash
484,600
490,900
446,200
601,800
Basic Shares
73,700
73,400
73,700
74,300

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$2,893,200
$2,949,800
$2,886,900
$2,831,600
Gross Profit
998,500
1,129,200
1,136,200
1,175,800
EBITDA
743,900
844,100
887,900
895,200
EBIT
588,500
706,800
767,300
772,900
Net Income
492,700
593,400
585,900
661,800
Net Change In Cash
2,893,200
2,949,800
2,886,900
2,831,600
Cost of Revenue
142,200
147,100
Free Cash Flow
276,400
414,500
439,400
330,600
Cash
484,600
853,900
894,300
762,600
Basic Shares
73,700
75,300
75,800
76,300

Earnings Calls

Quarter EPS
2024-12-31
$1.82
2024-09-30
$1.85
2024-06-30
$1.52
2024-03-31
$1.56